F
Fulcrum Therapeutics
FULC · NASDAQ · Healthcare
$3.89
+$0.12 (+3.18%) today
Loading live data...
Market Cap
$296.80M
24h Volume
$5.7M
P/E Ratio
0.0
52w High
$14.60
52w Low
$3.14
Est. AI Revenue
60%
Loading chart data...
7-Day Sparkline (Static)
About Fulcrum Therapeutics
Biotech leveraging AI-driven gene expression analysis and computational biology to develop small molecule therapies for genetically defined diseases.
CEO: Robert Gould
Founded: 2016
HQ: Cambridge, Massachusetts
Employees: 9
Performance
24 Hours+3.18%
7 Days+8.66%
30 Days+8.36%
1 Year-40.06%